Pharma Journalist -

Shire plc and Parion Sciences, Inc. announced they have entered into an agreement granting Shire exclusive worldwide rights to develop and commercialize P-321. Shire will lead…
Read More...

Agreement to buy F-Star Alpha and its lone asset, FS102 between Bristol-Myers Squibb and F-star Alpha has been terminated. Bristol-Myers Squibb and F-star Alpha, entered into an…
Read More...

Sorrento Therapeutics announced that it has successfully completed the transaction for acquisition of Virttu Biologics. In consideration for the acquisition, Virttu equity holders…
Read More...

TAPIMMUNE announced that Dr. Wilson has been appointed President after Dr.John Bonfiglio’s resigned as Chief Operating Officer, President and director of TapImmune Inc. to pursue other…
Read More...

The U.S. FDA approved Rydapt (midostaurin) in combination with Chemotherapy for the treatment of adult patients with newly diagnosed AML (acute myeloid leukemia) who have a specific…
Read More...

MedMira has received CE mark on its syphilis/HIV rapid test, Multiplo TP/HIV, this approval allows company to market and distribute the multiplex rapid test throughout the European…
Read More...

Allergan announced that it has completed the acquisition of ZELTIQ Aesthetics for $2.4 billion cash. ZELTIQ stockholders approved the transaction during the meeting held on April 27,…
Read More...

enGene announced that Theresa Podrebarac, has been appointed as the  Chief Medical Officer of the company. He will be responsible for designing and executing clinical development plan…
Read More...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Pfizer’s lorlatinib for the treatment of patients with anaplastic lymphoma kinase…
Read More...

Takeda Pharmaceutical has entered into a multi-year partnership with Harrington Discovery Institute at University Hospitals in Cleveland, Ohio to advance the development of rare disease…
Read More...